Pharmacology, Toxicology and Pharmaceutical Science
DNA
100%
DNA
95%
Host
54%
Parasite
54%
Antitubercular Activity
54%
Tuberculosis
54%
Acanthamoeba castellanii
54%
Amidinium
54%
Organisms
53%
DNA Topoisomerase
51%
Mycobacterium Tuberculosis
46%
Drug
36%
Gram Negative Bacterium
36%
Escherichia coli
36%
Cytotoxicity
35%
Acanthamoeba
32%
Antiparasitic Activity
27%
Chloroquine
27%
Dimer
25%
Infection
24%
Dimer
24%
Antimicrobial Agent
24%
Mouse
23%
Niosome
23%
IC50
21%
Tenidap
18%
Mycovirus
18%
Quinolone Derivative
18%
Diseases
18%
Staphylococcus Aureus
18%
Gram Positive Bacterium
18%
Amoxicillin
18%
Infectious Agent
18%
DNA Topoisomerase IV
18%
Electrospray Ionization
18%
Antibiotics
18%
Intercalating Agent
18%
Drug Development
18%
Effusion
18%
Antiplasmodial Activity
13%
Malaria
13%
Cross-Resistance
13%
Lead Compound
13%
Death
13%
Miltefosine
10%
Staphylococcus Aureus
10%
Acanthamoeba Keratitis
10%
Toxicity
10%
Escherichia coli
10%
Granulomatous Amebic Encephalitis
10%
Medicine and Dentistry
Mechanism of Action
80%
Parasite (Microbiology)
72%
Assay
62%
Tail
54%
Host
54%
Tuberculosis
54%
Oxide
54%
Immune Response
54%
Topoisomerase
51%
Mycobacterium Tuberculosis
46%
Dimer
44%
Escherichia coli
36%
Leishmaniasis
36%
Therapeutic Procedure
36%
Chemotherapeutic Agent
36%
Drug
36%
Organism
36%
Leishmania
27%
Bacterium
27%
Interference
25%
Relaxation
25%
Combination Therapy
25%
Niosome
23%
Mycovirus
18%
Gram-Positive Bacteria
18%
Effusion
18%
Intercalating Agent
18%
Electrospray Mass Spectrometry
18%
Tenidap
18%
Disease
18%
Recognition
18%
Nuclear Magnetic Resonance Spectroscopy
18%
Neglected Tropical Diseases
18%
Antibiotics
18%
Antiinfective Agent
18%
Amoxicillin
18%
Bacterial Growth
18%
Staphylococcus Aureus
18%
DNA Topoisomerase IV
18%
Pathogen
18%
Quinolone Derivative
18%
Gram-Negative Bacteria
18%
DNA Binding
15%
Aqueous
9%
Lead
9%
Multimodal Imaging
9%
Alkyne
9%
Morpholine
9%
Natural Product
9%
Flow Cytometry
7%
Biochemistry, Genetics and Molecular Biology
DNA
76%
Spectrum
63%
Mycobacterium Tuberculosis
54%
Mammalian Cell
54%
Clinical Trial
54%
Introspection
54%
Immune Response
54%
Raman Microscopy
54%
Host
54%
Topoisomerase
51%
Escherichia coli
36%
Gram Negative Bacterium
36%
Electric Potential
27%
Gyrase
25%
Non-Ionic Surfactant
23%
Mouse
23%
Quantitative Imaging
18%
Bacterial Growth
18%
Comprehension
18%
Mycovirus
18%
Microscopy
18%
Fluorescence
18%
Melting Point
18%
Nuclear Magnetic Resonance Spectroscopy
18%
Topoisomerase IV
18%
Cell-Cell Interaction
18%
Electrospray Mass Spectrometry
18%
Infectious Agent
18%
Recognition
18%
Solution and Solubility
18%
Imaging Technique
18%
Gram Positive Bacterium
18%
Staphylococcus Aureus
18%
DNA Binding
15%
Drug Screening
9%
Lysosome
9%
Development
9%
Binding Affinity
9%
Process Design
9%
Raman Spectroscopy
9%
DNA Damage
7%
Reduction (Chemistry)
7%
Flow Cytometry
7%
Proinflammatory Cytokine
7%
Immunocompetent Cell
7%
Mass Spectrometry
7%